Tricitrates (Sod/Pot/K Cit/Sod Cit/Cit Acid) Patent Expiration, LOE Window & CMS Spending

Tricitrates (Sod/Pot/K Cit/Sod Cit/Cit Acid) by Pai Holding, Ll: Off-Patent Genericized (AB Competition), 0 AB generics, $78K 2024 CMS Part D & Medicaid spend, and $1,863 CA SB 17 specialty launch WAC.

Regulatory & Reimbursement Dimension Verified Value
Consolidated SponsorPai Holding, Ll
FDA Application & PathwayReconciled (UNLINKED)
Exclusivity / Cliff HorizonOff-Patent Genericized (AB Competition)
Core Active-Ingredient LOE DateNot listed / N/A
Last Listed Patent or Exclusivity DateNot listed / N/A
Orange Book Patents (*PED Extensions)0 patents (0 *PED)
Active AB-Rated Generic Competitors0
2024 CMS Total Public Spend$78K
2024 Medicare Part D Spend$15K
2024 Medicaid Spend$62K
Reported Wholesale Price Change (CA SB 17)Specialty launch notice ($1,863 intro WAC)